Interpace Diagnostics Reports First Quarter 2019 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Interpace Diagnostics (IDXG) Misses Q1 EPS by 4c, Revenues Miss; Offers FY19 Revenue Outlook
May 13, 2019 4:12 PM EDTInterpace Diagnostics (NASDAQ: IDXG) reported Q1 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $6.01 million versus the consensus estimate of $6.33 million.
FIRST QUARTER 2019 FINANCIAL PERFORMANCE
Net Revenue was $6.01 million, an increase of 25% over the first quarter of 2018;Gross Profit was 56%, an improvement compared to 46% in the first quarter of 2018;Sales & marketing Expenses, were $2.4 million or 40% of Net Revenues an improvement as... More